Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease

Melissa M. Hudson, Carol Greenwald, Elizabeth Thompson, Judith Wilimas, Neyssa Marina, Diane Fairclough, William Kauffman, Paula Bozeman, Paul W. Mackert, Minnie Abromowitch, Jesse Jenkins, Thomas Boulden, Larry Kun

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Purpose: Between May 1980 and September 1990, 85 patients with Hodgkin's disease were treated with a regimen designed to increase cure rates while reducing late toxicity. Patients and Methods: Therapy consisted of five cycles of cyclophosphamide, Oncovin (vincristine; Eli Lilly and Co, Indianapolis, IN), and procarbazine (COP), alternated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and low-dose (20 Gy) regional radiotherapy. Vincristine and cyclophosphamide were administered as tolerated during irradiation and during the 2- to 4-week rest period between radiation volumes. The need for staging laparotomy was defined by clinical presentation. Results: The median age at diagnosis was 14 years (range, 4 to 20), and 56% of patients were male. The majority (67%) had stage III or IV disease and 68% (19 of 28) of stage II patients had bulky mediastinal disease. Nodular sclerosing histology predominated (67%). Ninety-three percent of patients were alive without disease with a median follow-up of 4.1 years. Abnormalities were detected on chest roentgenograms and/or pulmonary function tests in 58% and 25% of clinically asymptomatic patients who were tested at least 1 year after completion of therapy. The only symptomatic patient had pulmonary fibrosis after treatment with bleomycin (20 U/m2) and mantle (20 Gy)/lung (13 Gy) irradiation, and developed multiple spontaneous pneumothoraces that required cortical stripping. One patient had congestive heart failure 19 months post-treatment, and two had abnormalities on echocardiograms. Thyroid abnormalities occurred in 21 (27%) patients who were assessable for late toxicity. The majority of female patients have had regular menstrual cycles. Six developed ovarian failure, and 10 have had a total of 17 pregnancies. Other than one documented case of oligospermia, information was not available on male fertility. Conclusion: The results demonstrate excellent disease control for the COP/ABVD regimen, with acceptable toxicity.

Original languageEnglish (US)
Pages (from-to)100-108
Number of pages9
JournalJournal of Clinical Oncology
Volume11
Issue number1
DOIs
StatePublished - Jan 1 1993

Fingerprint

Hodgkin Disease
Radiotherapy
Drug Therapy
Vincristine
Bleomycin
Cyclophosphamide
Mediastinal Diseases
Procarbazine
Oligospermia
Dacarbazine
Vinblastine
Pulmonary Fibrosis
Respiratory Function Tests
Pneumothorax
Therapeutics
Menstrual Cycle
Doxorubicin
Laparotomy
Fertility
Histology

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease. / Hudson, Melissa M.; Greenwald, Carol; Thompson, Elizabeth; Wilimas, Judith; Marina, Neyssa; Fairclough, Diane; Kauffman, William; Bozeman, Paula; Mackert, Paul W.; Abromowitch, Minnie; Jenkins, Jesse; Boulden, Thomas; Kun, Larry.

In: Journal of Clinical Oncology, Vol. 11, No. 1, 01.01.1993, p. 100-108.

Research output: Contribution to journalArticle

Hudson, MM, Greenwald, C, Thompson, E, Wilimas, J, Marina, N, Fairclough, D, Kauffman, W, Bozeman, P, Mackert, PW, Abromowitch, M, Jenkins, J, Boulden, T & Kun, L 1993, 'Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease', Journal of Clinical Oncology, vol. 11, no. 1, pp. 100-108. https://doi.org/10.1200/JCO.1993.11.1.100
Hudson, Melissa M. ; Greenwald, Carol ; Thompson, Elizabeth ; Wilimas, Judith ; Marina, Neyssa ; Fairclough, Diane ; Kauffman, William ; Bozeman, Paula ; Mackert, Paul W. ; Abromowitch, Minnie ; Jenkins, Jesse ; Boulden, Thomas ; Kun, Larry. / Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease. In: Journal of Clinical Oncology. 1993 ; Vol. 11, No. 1. pp. 100-108.
@article{30ab1133305d4529aa09b706bea36952,
title = "Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease",
abstract = "Purpose: Between May 1980 and September 1990, 85 patients with Hodgkin's disease were treated with a regimen designed to increase cure rates while reducing late toxicity. Patients and Methods: Therapy consisted of five cycles of cyclophosphamide, Oncovin (vincristine; Eli Lilly and Co, Indianapolis, IN), and procarbazine (COP), alternated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and low-dose (20 Gy) regional radiotherapy. Vincristine and cyclophosphamide were administered as tolerated during irradiation and during the 2- to 4-week rest period between radiation volumes. The need for staging laparotomy was defined by clinical presentation. Results: The median age at diagnosis was 14 years (range, 4 to 20), and 56{\%} of patients were male. The majority (67{\%}) had stage III or IV disease and 68{\%} (19 of 28) of stage II patients had bulky mediastinal disease. Nodular sclerosing histology predominated (67{\%}). Ninety-three percent of patients were alive without disease with a median follow-up of 4.1 years. Abnormalities were detected on chest roentgenograms and/or pulmonary function tests in 58{\%} and 25{\%} of clinically asymptomatic patients who were tested at least 1 year after completion of therapy. The only symptomatic patient had pulmonary fibrosis after treatment with bleomycin (20 U/m2) and mantle (20 Gy)/lung (13 Gy) irradiation, and developed multiple spontaneous pneumothoraces that required cortical stripping. One patient had congestive heart failure 19 months post-treatment, and two had abnormalities on echocardiograms. Thyroid abnormalities occurred in 21 (27{\%}) patients who were assessable for late toxicity. The majority of female patients have had regular menstrual cycles. Six developed ovarian failure, and 10 have had a total of 17 pregnancies. Other than one documented case of oligospermia, information was not available on male fertility. Conclusion: The results demonstrate excellent disease control for the COP/ABVD regimen, with acceptable toxicity.",
author = "Hudson, {Melissa M.} and Carol Greenwald and Elizabeth Thompson and Judith Wilimas and Neyssa Marina and Diane Fairclough and William Kauffman and Paula Bozeman and Mackert, {Paul W.} and Minnie Abromowitch and Jesse Jenkins and Thomas Boulden and Larry Kun",
year = "1993",
month = "1",
day = "1",
doi = "10.1200/JCO.1993.11.1.100",
language = "English (US)",
volume = "11",
pages = "100--108",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "1",

}

TY - JOUR

T1 - Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with hodgkin's disease

AU - Hudson, Melissa M.

AU - Greenwald, Carol

AU - Thompson, Elizabeth

AU - Wilimas, Judith

AU - Marina, Neyssa

AU - Fairclough, Diane

AU - Kauffman, William

AU - Bozeman, Paula

AU - Mackert, Paul W.

AU - Abromowitch, Minnie

AU - Jenkins, Jesse

AU - Boulden, Thomas

AU - Kun, Larry

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Purpose: Between May 1980 and September 1990, 85 patients with Hodgkin's disease were treated with a regimen designed to increase cure rates while reducing late toxicity. Patients and Methods: Therapy consisted of five cycles of cyclophosphamide, Oncovin (vincristine; Eli Lilly and Co, Indianapolis, IN), and procarbazine (COP), alternated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and low-dose (20 Gy) regional radiotherapy. Vincristine and cyclophosphamide were administered as tolerated during irradiation and during the 2- to 4-week rest period between radiation volumes. The need for staging laparotomy was defined by clinical presentation. Results: The median age at diagnosis was 14 years (range, 4 to 20), and 56% of patients were male. The majority (67%) had stage III or IV disease and 68% (19 of 28) of stage II patients had bulky mediastinal disease. Nodular sclerosing histology predominated (67%). Ninety-three percent of patients were alive without disease with a median follow-up of 4.1 years. Abnormalities were detected on chest roentgenograms and/or pulmonary function tests in 58% and 25% of clinically asymptomatic patients who were tested at least 1 year after completion of therapy. The only symptomatic patient had pulmonary fibrosis after treatment with bleomycin (20 U/m2) and mantle (20 Gy)/lung (13 Gy) irradiation, and developed multiple spontaneous pneumothoraces that required cortical stripping. One patient had congestive heart failure 19 months post-treatment, and two had abnormalities on echocardiograms. Thyroid abnormalities occurred in 21 (27%) patients who were assessable for late toxicity. The majority of female patients have had regular menstrual cycles. Six developed ovarian failure, and 10 have had a total of 17 pregnancies. Other than one documented case of oligospermia, information was not available on male fertility. Conclusion: The results demonstrate excellent disease control for the COP/ABVD regimen, with acceptable toxicity.

AB - Purpose: Between May 1980 and September 1990, 85 patients with Hodgkin's disease were treated with a regimen designed to increase cure rates while reducing late toxicity. Patients and Methods: Therapy consisted of five cycles of cyclophosphamide, Oncovin (vincristine; Eli Lilly and Co, Indianapolis, IN), and procarbazine (COP), alternated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and low-dose (20 Gy) regional radiotherapy. Vincristine and cyclophosphamide were administered as tolerated during irradiation and during the 2- to 4-week rest period between radiation volumes. The need for staging laparotomy was defined by clinical presentation. Results: The median age at diagnosis was 14 years (range, 4 to 20), and 56% of patients were male. The majority (67%) had stage III or IV disease and 68% (19 of 28) of stage II patients had bulky mediastinal disease. Nodular sclerosing histology predominated (67%). Ninety-three percent of patients were alive without disease with a median follow-up of 4.1 years. Abnormalities were detected on chest roentgenograms and/or pulmonary function tests in 58% and 25% of clinically asymptomatic patients who were tested at least 1 year after completion of therapy. The only symptomatic patient had pulmonary fibrosis after treatment with bleomycin (20 U/m2) and mantle (20 Gy)/lung (13 Gy) irradiation, and developed multiple spontaneous pneumothoraces that required cortical stripping. One patient had congestive heart failure 19 months post-treatment, and two had abnormalities on echocardiograms. Thyroid abnormalities occurred in 21 (27%) patients who were assessable for late toxicity. The majority of female patients have had regular menstrual cycles. Six developed ovarian failure, and 10 have had a total of 17 pregnancies. Other than one documented case of oligospermia, information was not available on male fertility. Conclusion: The results demonstrate excellent disease control for the COP/ABVD regimen, with acceptable toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0027447337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027447337&partnerID=8YFLogxK

U2 - 10.1200/JCO.1993.11.1.100

DO - 10.1200/JCO.1993.11.1.100

M3 - Article

C2 - 8418221

AN - SCOPUS:0027447337

VL - 11

SP - 100

EP - 108

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 1

ER -